| GENPHARMASEC  Back to All Ratios | 
GENPHARMASEC Last 5 Year EBIT Margin History
[Consolidated]
| Mar2024 | Mar2023 | |
|---|---|---|
| EBIT Margin(%) | 2.17 | 1.32 | 
What is the latest EBIT Margin ratio of GENPHARMASEC ?
| Year | EBIT Margin | 
|---|---|
| Mar2024 | 2.17 | 
| Mar2023 | 1.32 | 
How is EBIT Margin of GENPHARMASEC Trending?
| Years | EBIT Margin | % Change | |
|---|---|---|---|
| Mar2024 | 2.17 | 64.39 | |
| Mar2023 | 1.32 | - | |
Other Financial Ratios of GENPHARMASEC
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap | 
Compare EBIT Margin ratio of peers of GENPHARMASEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENPHARMASEC | ₹92.5 Cr | -5.7% | -12.1% | -31.5% | Stock Analytics | |
| SUDARSHAN CHEMICAL INDUSTRIES | ₹9,255.9 Cr | -1.7% | -13.1% | 25.4% | Stock Analytics | |
| KIRI INDUSTRIES | ₹3,295.5 Cr | -3.7% | -1% | 50% | Stock Analytics | |
| VIDHI SPECIALTY FOOD INGREDIENTS | ₹1,694.9 Cr | -1.4% | -4.3% | -25.1% | Stock Analytics | |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | ₹1,361.1 Cr | 1.3% | -4.5% | 71.6% | Stock Analytics | |
| BODAL CHEMICALS | ₹768.8 Cr | 0.4% | -1.9% | -16.7% | Stock Analytics | |
GENPHARMASEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| GENPHARMASEC | -5.7% | -12.1% | -31.5% | 
| SENSEX | -0.2% | 5% | 5.4% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    